Table 1.
Time in phase | No drug |
Morlin |
||
---|---|---|---|---|
(+) | (−) | (+) | (−) | |
Growth, % | 62.4 | 1.9 | 69.1 | 4.0 |
Pause, % | 1.0 | 20.5 | 2.9 | 45.3 |
Shorten, % | 36.6 | 77.6 | 28.0 | 50.7 |
Dynamicity, μm/min | 7.4 ± 4.9 | 0.4 ± 0.4 | 3.5 ± 2.7 | 0.3 ± 0.3 |
Net polymer gain, μm/min | 1.2 | −0.4 | 0.4 | −0.2 |
Data are derived from the same population of measurements as described in Fig. 3. (+) denotes the presumed plus end, and (−) denotes the presumed minus end.